• Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 29 Sep 2024 03:11:11   America/New_York


    Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat September 29, 2024 Share Link copied to clipboard. Madrigal Pharmaceuticals, Inc.
    Read more...
Share on,